Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEDAPLATIN: 738 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
738
Total FAERS Reports
94 (12.7%)
Deaths Reported
282
Hospitalizations
738
As Primary/Secondary Suspect
77
Life-Threatening
18
Disabilities

First Report: 200604 · Latest Report: 20250920

What Are the Most Common NEDAPLATIN Side Effects?

#1 Most Reported
Myelosuppression
272 reports (36.9%)
#2 Most Reported
White blood cell count decreased
61 reports (8.3%)
#3 Most Reported
Thrombocytopenia
51 reports (6.9%)

All NEDAPLATIN Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Myelosuppression 272 36.9% 9 151
White blood cell count decreased 61 8.3% 0 27
Thrombocytopenia 51 6.9% 9 7
Off label use 49 6.6% 2 20
Neutropenia 45 6.1% 5 3
Neutrophil count decreased 41 5.6% 0 15
Bone marrow failure 35 4.7% 4 10
Gastrointestinal disorder 35 4.7% 1 4
Platelet count decreased 35 4.7% 0 15
Disease progression 33 4.5% 14 3
Nausea 30 4.1% 4 6
Anaemia 29 3.9% 6 11
Febrile neutropenia 27 3.7% 10 6
Diarrhoea 26 3.5% 6 7
Vomiting 26 3.5% 3 5
Acute myeloid leukaemia 24 3.3% 16 3
Leukopenia 23 3.1% 1 7
Myelodysplastic syndrome 23 3.1% 18 4
Drug ineffective 21 2.9% 8 1
Pyrexia 19 2.6% 4 12

Who Reports NEDAPLATIN Side Effects? Age & Gender Data

Gender: 40.5% female, 59.5% male. Average age: 59.0 years. Most reports from: CN. View detailed demographics →

Is NEDAPLATIN Getting Safer? Reports by Year

YearReportsDeathsHosp.
2006 1 1 0
2007 1 0 1
2008 1 1 1
2011 5 2 5
2013 2 1 0
2014 5 1 2
2015 6 2 2
2016 6 1 3
2017 3 0 1
2018 13 0 3
2019 26 2 14
2020 30 1 13
2021 26 3 16
2022 31 0 15
2023 40 0 21
2024 137 0 80
2025 32 0 21

View full timeline →

What Is NEDAPLATIN Used For?

IndicationReports
Oesophageal carcinoma 92
Lung neoplasm malignant 71
Nasopharyngeal cancer 46
Chemotherapy 36
Cervix carcinoma 28
Germ cell cancer 25
Lung adenocarcinoma 25
Ovarian cancer 20
Oesophageal squamous cell carcinoma 17
Metastases to lymph nodes 15

NEDAPLATIN vs Alternatives: Which Is Safer?

NEDAPLATIN vs NEFAZODONE NEDAPLATIN vs NEFOPAM NEDAPLATIN vs NEISSERIA MENINGITIDIS GROUP B FHBP FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NADA PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN ANTIGEN\NEISSERIA MENINGITIDIS GROUP B STRAIN NZ98/254 OUTER MEMBRANE VESICLE\NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIG NEDAPLATIN vs NELARABINE NEDAPLATIN vs NELFINAVIR NEDAPLATIN vs NELVUTAMIG NEDAPLATIN vs NEMOLIZUMAB NEDAPLATIN vs NEMOLIZUMAB-ILTO NEDAPLATIN vs NEOMYCIN NEDAPLATIN vs NEORAL

Official FDA Label for NEDAPLATIN

Official prescribing information from the FDA-approved drug label.